Disisomicinpentakis(sulfat) Produkt Beschreibung

Sisomycin Sulfate Struktur
53179-09-2
  • CAS-Nr.53179-09-2
  • Bezeichnung:Disisomicinpentakis(sulfat)
  • Englisch Name:Sisomycin Sulfate
  • Synonyma:Disisomicinpentakis(sulfat)
    sisomin;mensiso;Baymicin;Sisolline;extramycin;pathomycin;Sisobiotic;sisomycinsulfate;SISOMICIN SULFATE;SISOMYCIN SULPHATE
  • CBNumber:CB5402393
  • Summenformel:C19H39N5O11S
  • Molgewicht:545.61
  • MOL-Datei:53179-09-2.mol
Disisomicinpentakis(sulfat) physikalisch-chemischer Eigenschaften
  • Schmelzpunkt: :70-73C
  • Siedepunkt: :155℃
  • Flammpunkt: :>110°(230°F)
  • storage temp.  :Keep in dark place,Inert atmosphere,2-8°C
  • Löslichkeit :H2O: soluble50mg/mL
  • Aggregatzustand :powder
  • Farbe :white to off-white
  • Optische Aktivität :[α]25/D 100 to 110° in water (Specific rotation (anhydrous), C=1)
  • Wasserlöslichkeit :Soluble in water
  • Merck  :14,8550
Sicherheit
  • Kennzeichnung gefährlicher :T,Xi
  • R-Sätze: :61-20/21/22-36/37/38
  • S-Sätze: :53-22-36/37/39-45-36-26
  • WGK Germany  :3
  • RTECS-Nr. :WK2288000
  • HS Code  :2941901010
  • Toxizität :LD50 in mice (mg/kg): 34 i.v., 221 i.p., 288 s.c. (Weinstein)

Sisomycin Sulfate Chemische Eigenschaften,Einsatz,Produktion Methoden

  • R-Sätze Betriebsanweisung: R61:Kann das Kind im Mutterleib schädigen.
    R20/21/22:Gesundheitsschädlich beim Einatmen,Verschlucken und Berührung mit der Haut.
    R36/37/38:Reizt die Augen, die Atmungsorgane und die Haut.
  • S-Sätze Betriebsanweisung: S53:Exposition vermeiden - vor Gebrauch besondere Anweisungen einholen.
    S22:Staub nicht einatmen.
    S36/37/39:Bei der Arbeit geeignete Schutzkleidung,Schutzhandschuhe und Schutzbrille/Gesichtsschutz tragen.
    S45:Bei Unfall oder Unwohlsein sofort Arzt zuziehen (wenn möglich, dieses Etikett vorzeigen).
    S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen.
    S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.
  • Originator Pathomyci n,Byk-Essex,W. Germany,1976
  • Verwenden antibacterial, binds to ribosomes
  • Manufacturing Process Tank fermentation of Micromonospora inyoensis - Germination stage 1: Under aseptic conditions, add a lyophilized culture (or cells obtained from a slant culture) of M. inyoensis to a 300 ml shake flask containing 100 ml of the following sterile medium: Beef extract 3 g Tryptone 5 g Yeast extract 5 g Dextrose 1 g Starch 24 g Calcium carbonate 2 g Tap water 1,000 ml Incubate the flask and its contents for 5 days at 35°C on a rotary shaker (280 rpm, 2'' stroke).Germination stage 2: Aseptically transfer 25 ml of the fermentation medium of Germination stage 1 to a 2-l shake flask containing 500 ml of the above described sterile germination medium. Incubate the flask and its contents for 3 days at 28{]C on a rotary shaker (280 rpm, 2'' stroke).
    Fermentation stage: Aseptically transfer 500 ml of the medium obtained from Germination stage 2 to a 14-l fermentation tank containing 9.5 l of the following sterile medium: Dextrin 50 g Dextrose 5 g Soybean meal 35 g Calcium carbonate 7 g Cobalt chloride 10-6M Tap water 1,000 ml Antifoam (GE 60) 10 ml Prior to sterilizing the above described medium, adjust the pH to 8. Aerobically ferment for 66 to 90 hours while stirring at 250 rpm with air input at 4.5 l/l/min and 25 psi. The potency of the antibiotic produced at the end of this period reaches a peak of 150 to 225 mcm/ml and remains relatively constant. The pH of the fermentation medium changes slightly during the antibiotic production, varying in the range of 6.8 to 7.3.
    Isolation of Antibiotic 66-40 - The whole broth is adjusted to pH 2 with 6N sulfuric acid. (For the purpose of this example, quantities are given in terms of 170 l of fermentation broth obtained by pooling acidified broth from 17 batches.) The acidified broth is stirred for about 15 minutes and then filtered. Wash the mycelium with water and combine the washings with the filtrate. Adjust the pH of the filtrate to 7 with 6N ammonium hydroxide.
    To the neutralized filtrate, add sufficient oxalic acid to precipitate calcium and filter. Reneutralize the filtrate with ammonium hydroxide. Charge the filtrate onto a cationic exchange adsorption column containing 1,500 to 2,000 g of IRC-50 Amberlite in its ammonium form. Discard the eluate, wash the resin with water, and elute with 2N ammonium hydroxide. Collect 400 ml fractions and monitor by disc testing with S. aureus ATCC-6538P. Combine active fractions and evaporate to dryness under vacuum obtaining about 28 g of crude Antibiotic 6640 having an activity of about 500 mcm/g.
    Purification of Antibiotic 66-40 - Dissolve 28 g of crude Antibiotic 6640 in 100 ml of distilled water and charge to an anion exchange adsorption column (Dowex 1 x 2) in the hydroxyl form. Slurry 2,000 g of the resin in water into a column 2,5" in diameter and 36" high. Elute the column with distilled water at a rate of about 23 ml/min collecting 100 ml fractions and monitor with a conductivity meter and by disc testing against Staphylococcus aureus.
    The disc testing provides a gross separation of antibiotic-containing eluate fractions from those devoid of antibiotic. To insure that the fractions are properly combined, a portion of each fraction is paper chromatographed using the lower phase of a chloroform:methanol:17% ammonium hydroxide system (2:1:1). Each paper is sprayed with ninhydrin and the eluates containing like material are combined and lyophilized yielding about 5.7 g of Antibiotic 66-40 assaying about 900 mcm/mg.
  • Trademarks Siseptin (Schering).
  • Therapeutic Function Antibiotic
  • Clinical Use Although Sisomycin Sulfate has been approved for human use in theUnited States, it has not been marketed in this country. Itsantibacterial potency and effectiveness against aminoglycoside-inactivating enzymes resemble those of gentamicin.Sisomicin also exhibits pharmacokinetics and pharmacologicalproperties similar to those of gentamicin.
  • Sicherheitsprofil Poison by intravenous,intramuscular, intraperitoneal, and subcutaneous routes. When heated to decomposition itemits very toxic fumes of SOx and NOx.
Sisomycin Sulfate Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Disisomicinpentakis(sulfat) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global(160)Suppliers
  • Firmenname:Henan DaKen Chemical CO.,LTD.
  • Telefon:+86-371-66670886
  • Fax:
  • E-Mail:info@dakenchem.com
  • Land:China
  • Produktkatalog:20891
  • Edge Rate:58
  • Firmenname:Henan Tianfu Chemical Co.,Ltd.
  • Telefon:0371-55170693
  • Fax:0371-55170693
  • E-Mail:info@tianfuchem.com
  • Land:CHINA
  • Produktkatalog:22607
  • Edge Rate:55
  • Firmenname:Hubei XinRunde Chemical Co., Ltd.
  • Telefon:+8615102730682
  • Fax:02783214688
  • E-Mail:bruce@xrdchem.cn
  • Land:CHINA
  • Produktkatalog:567
  • Edge Rate:55
  • Firmenname:career henan chemical co
  • Telefon:+86-371-86658258
  • Fax:
  • E-Mail:sales@coreychem.com
  • Land:CHINA
  • Produktkatalog:29954
  • Edge Rate:58
  • Firmenname:Hubei Jusheng Technology Co.,Ltd.
  • Telefon:86-18871470254
  • Fax:027-59599243
  • E-Mail:linda@hubeijusheng.com
  • Land:CHINA
  • Produktkatalog:28229
  • Edge Rate:58
  • Firmenname:Xiamen AmoyChem Co., Ltd
  • Telefon:+86 592-605 1114
  • Fax:
  • E-Mail:sales@amoychem.com
  • Land:CHINA
  • Produktkatalog:6369
  • Edge Rate:58
  • Firmenname:BOC Sciences
  • Telefon:1-631-485-4226
  • Fax:1-631-614-7828
  • E-Mail:inquiry@bocsci.com
  • Land:United States
  • Produktkatalog:19752
  • Edge Rate:58
  • Firmenname:Chongqing Chemdad Co., Ltd
  • Telefon:+86-13650506873
  • Fax:
  • E-Mail:sales@chemdad.com
  • Land:CHINA
  • Produktkatalog:37282
  • Edge Rate:58
  • Firmenname:CONIER CHEM AND PHARMA LIMITED
  • Telefon:86-18523575427
  • Fax:
  • E-Mail:sales@conier.com
  • Land:CHINA
  • Produktkatalog:47498
  • Edge Rate:58
53179-09-2, Sisomycin Sulfate Verwandte Suche:
  • 6)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-glycero-hex-4-enopyranosyl-(1-4))
  • antibiotic66-40sulfate
  • extramycin
  • Sulfuric acid west shuttle m star
  • Sisomicin sulfate, 580 IU/mg
  • mensiso
  • pathomycin
  • sisomin
  • sisomycinsulfate
  • SISOMICIN SULFATE SALT
  • SISOMYCIN SULPHATE
  • SISOMICIN SULFATE
  • O-3-DEOXY-4-C-METHYL-3-METHYLAMINO-BETA-L-ARABINOPYRANOSYL-(1->6)-O-[2, 6-DIAMINO-4,5-DEHYDRO-2,3,4,6-TETRADEOXY-A-D-GLYCERO-HEXOPYRANOSYL-(1->4)]-2-DEOXY-D-STREPTAMINE HEMIHEPTASULFATE
  • Sisomicin sulfate, >98%
  • Baymicin
  • D-Streptamine, O-3-deoxy-4-C-methyl-3-(methylamino)-b-L-arabinopyranosyl-(16)-O-[2,6-diamino-2,3,4,6-tetradeoxy-a-D-glycero-hex-4-enopyranosyl-(14)]-2-deoxy-, sulfate (2:5) (salt) (9CI)
  • Sisobiotic
  • Sisolline
  • O-3-Deoxy-4-C-methyl-3-methylamino-ss-L-arabinopyranosyl-(1->6)-O-[2, 6-diamino-4, 5-dehydro-2,3,4,6-tetradeoxy-a-D-glycero-hexopyranosyl-(1->4)]-2-deoxy-D-streptamine hemiheptasulfate
  • O-3-Deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl-(1-4)]-2-deoxy-D-streptamine sulfate
  • Sissomicin sulfate
  • Sisomicin Sulfate (500 mg)
  • SisoMicin Sulfate Salt, USP
  • disisomicin pentakis(sulphate)
  • D-StreptaMine, O-3-deoxy-4-C-Methyl-3-(MethylaMino)-β-L-arabinopyranosyl-(1→6)-O-[2,6-diaMino-2,3,4,6-tetradeoxy-α-D-glycero-hex-4-enopyranosyl-(1→4)]-2-deoxy-, sulfate (2:5) (salt)
  • Sisomicin sulfate, >=580 μg/mg
  • Sisomicin sulfate CRS
  • Sisomycin Sulfate USP/EP/BP
  • Disisomicinpentakis(sulfat)
  • 53179-09-2
  • C19H37N5O72sup1sup2H2SO4
  • C19H37N5O75H2SO4
  • 2C19H37N5O75H2SO4
  • C19H37N5O725H2SO4
  • C19H37N5O7H2SO4
  • C38H84N10O34S5
  • BioChemical
  • Antibiotics N-S
  • Antibiotics A to Z
  • Antibiotics
  • SISEPTIN
  • AminoglycosidesAntibiotics
  • Antibacterial
  • Antibiotics
  • Antibiotics A to
  • Antibiotics N-SAntibiotics
  • Chemical Structure Class
  • Interferes with Protein SynthesisSpectrum of Activity
  • L - Z
  • Mechanism of Action